The current use of Alzheimer disease (AD) related amyloid/tau/neurodegeneration profile is made with the a priori idea that the first cognitive changes follows the elevation of brain amyloid and accumulation of neurofibrillary tangles (Soldan et al., 2019). This evidence concerns the gene MAPT and Alzheimer disease.